Bristol-Myers, Ono Pharmaceutical sales and marketing update

Ono and Bristol-Myers launched subcutaneous Orencia abatacept in Japan to treat rheumatoid arthritis. The product has a Japanese National Health Insurance (NHI) list price of ¥27,171 ($278.77) per 12...